Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on page content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page metadata.SummaryDifference0.0%

- Check56 days agoChange DetectedExpanded and revised the Locations section by adding state site listings (CA, CO, FL, IL, MA, MO, NY, NC, OH, OK, TN, TX, WI) and removing prior state entries. This changes which study sites are listed and where participants can enroll.SummaryDifference1%

- Check77 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision to v3.3.2. Removed the previous note indicating PubMed publications are automatically created by ClinicalTrials.gov and linked to the study, with the revision updated to v3.2.0.SummaryDifference0.1%

- Check85 days agoChange DetectedThe funding-status notice at the top of the page was removed. This banner was a generic operating-status message not related to the study details.SummaryDifference0.2%

- Check107 days agoChange DetectedNo meaningful changes in the study details or structure are observed between the screenshots.SummaryDifference0.3%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.